Low human papillomavirus prevalence in head and neck cancer: results from two large case-control studies in high-incidence regions. (Q54393225)

29 May 2018

title

Low human papillomavirus prevalence in head and neck cancer: results from two large case-control studies in high-incidence regions. (English)

1 reference

29 May 2018

1 reference

1 reference

head and neck carcinoma

1 reference

3

1 reference

29 May 2018

Jose Eluf-neto

6

1 reference

29 May 2018

Maria Paula Curado

8

1 reference

29 May 2018

Jolanta Lissowska

12

1 reference

29 May 2018

Vladimír Bencko

15

1 reference

29 May 2018

Dana Mates

Dana Mates

16

0 references

David Zaridze

10

David Zaridze

1 reference

29 May 2018

18

Eleonora Fabianova

1 reference

PubMed ID

21224273

Neonila Szeszenia-Dabrowska

29 May 2018

11

Neonila Szeszenia-Dabrowska

1 reference

29 May 2018

21

Paolo Boffetta

1 reference

29 May 2018

23

Tim Waterboer

1 reference

29 May 2018

2

José Eduardo Levi

1 reference

29 May 2018

9

Oxana Shangina

1 reference

29 May 2018

Elena Matos

5

Elena Matos

1 reference

29 May 2018

Tarik Gheit

19

Tarik Gheit

1 reference

29 May 2018

Massimo Tommasino

20

Massimo Tommasino

1 reference

29 May 2018

Alexander W Daudt

13

Alexander Daudt

1 reference

29 May 2018

Victor Wünsch-Filho

7

Victor Wunsch-Filho

1 reference

29 May 2018

Karina Braga Ribeiro

1

Karina Braga Ribeiro

1 reference

29 May 2018

Sérgio Koifman

4

Sérgio Koifman

1 reference

29 May 2018

author name string

Ana Menezes

14

1 reference

29 May 2018

Letícia Fernandez

17

1 reference

29 May 2018

Paul Brennan

22

1 reference

29 May 2018

publication date

11 January 2011

1 reference

29 May 2018

International Journal of Epidemiology

published in

1 reference

29 May 2018

volume

40

1 reference

29 May 2018

page(s)

489-502

1 reference

29 May 2018

issue

2

1 reference

29 May 2018

Role of human papillomaviruses in cancer of the respiratory and upper digestive tract.

cites work

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYQ249

Biological evidence that human papillomaviruses are etiologically involved in a subgroup of head and neck squamous cell carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYQ249

Involvement of intact HPV16 E6/E7 gene expression in head and neck cancers with unaltered p53 status and perturbed pRb cell cycle control.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYQ249

Case-control study of human papillomavirus and oropharyngeal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYQ249

Human papillomavirus-associated head and neck squamous cell carcinoma: mounting evidence for an etiologic role for human papillomavirus in a subset of head and neck cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYQ249

Human papillomavirus-associated head and neck cancer is a distinct epidemiologic, clinical, and molecular entity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYQ249

Human papillomavirus and oral cancer: the International Agency for Research on Cancer multicenter study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYQ249

Human papillomavirus and head and neck cancer: a systematic review and meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYQ249

Human papillomavirus and risk of oral cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYQ249

Human Papillomavirus Types in Head and Neck Squamous Cell Carcinomas Worldwide: A Systematic Review

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYQ249

Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYQ249

Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYQ249

HPV prophylactic vaccines and the potential prevention of noncervical cancers in both men and women

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYQ249

HPV in oral squamous cell carcinomas of a Brazilian population: amplification by PCR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYQ249

The serological response to papillomaviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYQ249

Oral cancer risk in relation to sexual history and evidence of human papillomavirus infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYQ249

Human papillomavirus infection and oral cancer: a case-control study in Montreal, Canada.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYQ249

Human papillomavirus seropositivity and risks of head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYQ249

Lack of association of alcohol and tobacco with HPV16-associated head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYQ249

A generic capture ELISA for recombinant proteins fused to glutathione S-transferase: validation for HPV serology

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYQ249

HPV antibody detection by ELISA with capsid protein L1 fused to glutathione S-transferase

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYQ249

Multiplex human papillomavirus serology based on in situ-purified glutathione s-transferase fusion proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYQ249

Suppression of non-specific binding in serological Luminex assays

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYQ249

Serologic response to oncogenic human papillomavirus types in male and female university students in Busan, South Korea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYQ249

Seroprevalence of 34 human papillomavirus types in the German general population

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYQ249

Use of PGMY primers in L1 consensus PCR improves detection of human papillomavirus DNA in genital samples

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYQ249

Identification and assessment of known and novel human papillomaviruses by polymerase chain reaction amplification, restriction fragment length polymorphisms, nucleotide sequence, and phylogenetic algorithms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYQ249

Recent changes in the epidemiology of head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYQ249

Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYQ249

Tongue and tonsil carcinoma: increasing trends in the U.S. population ages 20-44 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYQ249

Incidence and survival of squamous cell carcinoma of the tongue in Scandinavia, with special reference to young adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYQ249

Demographic and risk factors in patients with head and neck tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYQ249

TP53 and EGFR mutations in combination with lifestyle risk factors in tumours of the upper aerodigestive tract from South America

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYQ249

Does pretreatment seropositivity to human papillomavirus have prognostic significance for head and neck cancers?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYQ249

Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYQ249

Exploring the relation between human papilloma virus and larynx cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYQ249

A review of human carcinogens--Part B: biological agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYQ249

Age, sexual behavior and human papillomavirus infection in oral cavity and oropharyngeal cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYQ249

Oral sexual behaviors associated with prevalent oral human papillomavirus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYQ249

Fundamental differences in cell cycle deregulation in human papillomavirus-positive and human papillomavirus-negative head/neck and cervical cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYQ249

Oral Health and Risk of Squamous Cell Carcinoma of the Head and Neck and Esophagus: Results of Two Multicentric Case-Control Studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYQ249

HPV16 semiquantitative viral load and serologic biomarkers in oral and oropharyngeal squamous cell carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYQ249

Human Papillomavirus and Risk of Laryngeal Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYQ249

21 January 2018

Identifiers

DOI

10.1093/IJE/DYQ249

1 reference

29 May 2018

PubMed ID

21224273

1 reference

29 May 2018